普通人群中未诊断法布雷病的群体频率
本研究利用基因组聚集数据库(gnomAD),基于变异罕见性和4种计算工具的转录效应及脊椎动物氨基酸保守性预测GLA致病性变异,估算普通人群中未诊断法布雷病的患病率。预测致病性GLA变异在gnomAD人群中频率为1/3225,在对照亚组中为1/3478,女性比预期更常见(3.1:1)。研究结论认为法布雷病比既往认识更常见,尤其在女性中仍被低估。
要点
- 预测致病性GLA变异在gnomAD人群中频率为1/3225,对照亚组为1/3478。
- 预测致病性变异在女性中更常见,女性与男性比例为3.1:1。
- 南亚、德系犹太和芬兰血统人群中未发现预测致病性变异。
核心结论
- 普通人群中未诊断法布雷病的群体频率为1/3225,该数值仍为低估,因致病性判定标准严格、队列未包含已诊断个体、全外显子测序不检测内含子变异和大片段缺失。
- 本研究证实法布雷病比既往认识更常见,尤其在女性中仍被低估。
研究设计与样本
- 基于基因组聚集数据库(gnomAD)的变异分析,依据变异罕见性(≤5)和4种计算工具(CADD >20、PP2 >0.95、SIFT <0.05、Mutation Taster - Disease-causing)的转录效应及Clustal中脊椎动物氨基酸保守性预测GLA致病性变异。
主要发现
- 预测致病性GLA变异在gnomAD人群中频率为1/3225,在gnomAD对照亚组中频率为1/3478。
- 预测致病性变异在女性中比预期更常见,女性与男性比例为3.1:1,这与男性因法布雷并发症被排除于gnomAD之外一致。
- 在该队列中,南亚、德系犹太或芬兰血统成员中未发现预测致病性变异。
- 在法布雷数据库中被认定为致病性的变异在gnomAD数据库个体中频率为1/2651,来自ClinVar的致病性变异频率为1/4420。
关键数值与推荐
- 预测致病性变异判定标准:变异罕见性≤5,且满足CADD >20、PP2 >0.95、SIFT <0.05、Mutation Taster - Disease-causing,并在Clustal中显示脊椎动物氨基酸保守。
- gnomAD人群中预测致病性GLA变异频率为1/3225,gnomAD对照亚组为1/3478。
- 法布雷数据库致病性变异在gnomAD中频率为1/2651,ClinVar致病性变异在gnomAD中频率为1/4420。
- 预测致病性变异女性与男性比例为3.1:1。
局限性
- 致病性判定标准严格,导致1/3225的频率仍为低估。
- 队列未包含已诊断个体。
- 全外显子测序不检测内含子变异和大片段缺失。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Fabry disease is an X-linked disorder that results from pathogenic GLA variants and can now be treated. Most studies of its population frequency have examined only males or attendees at kidney failure or cardiac clinics. This study determined the prevalence of undiagnosed Fabry disease from predicted pathogenic GLA variants in the general population. METHODS: The Genome Aggregation Database (gnomAD) was examined for predicted pathogenic GLA variants based on variant rarity (≤5), and transcript effect in 4 computational tools (CADD >20, PP2 >0.95, SIFT <0.05, Mutation Taster - Disease-causing) and amino acid conservation in vertebrates in a Clustal. RESULTS: Predicted pathogenic variants in GLA occurred in 1 in 3225 of the gnomAD population and 1 in 3478 of its control subset. Predicted pathogenic variants were more common in women than expected (3.1:1), which is consistent with men being excluded from gnomAD because of Fabry complications. Predicted pathogenic variants were not found in members of this cohort with South Asian, Ashkenazim, or Finnish ancestries. Variants identified as pathogenic in the Fabry database were found in 1 in 2651 individuals of the gnomAD database and pathogenic variants from ClinVar in 1 in 4420. DISCUSSION: The population frequency of 1 in 3225 for undiagnosed men and women with Fabry disease still represents an underestimate because our pathogenicity criteria were rigorous, the cohort did not include already-diagnosed individuals, and whole exome sequencing does not detect intronic variants and large deletions. This study confirms that Fabry disease is more common than previously recognized and still underdiagnosed especially in women.
引用
- Kermond-Marino A, Weng A, Xi Zhang SK, et al. Population Frequency of Undiagnosed Fabry Disease in the General Population. Kidney Int Rep. 2023. PMID: 37441486. doi:10.1016/j.ekir.2023.04.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。